Another immune checkpoint that is constitutively expressed on Tregs is glucocorticoid-induced TNFR related protein (GITR), and antibodies against GITR, provide another pathway for targeting this suppressive cell type with promising data coming from glioma models (190). This evidence concerns the gene TNFRSF18 and central nervous system cancer.